trending Market Intelligence /marketintelligence/en/news-insights/trending/xyldvcgqzfful68u2or0lq2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Medovex acquires lung disease therapy provider

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Medovex acquires lung disease therapy provider

MedoveX Corp. has made its first acquisition under newly appointed CEO William Horne.

The Alpharetta, Ga.-based company — formed to acquire and develop a portfolio of medical technology products and services — said it entered a definitive agreement to acquire the pulmonary biomedical services and patient delivery platform of Regenerative Medicine Solutions LLC in an all-stock deal.

The acquisition reunites Laser Spine Institute's executive management team with Horne, who founded the medical device company and served as its CEO.

Regenerative Medicine Solutions is a Tampa, Fla.-based biomedical services company that manages all five clinics of Lung Health Institute, a provider of cellular therapies to treat chronic obstructive pulmonary disease, or COPD, and other chronic lung disorders.

COPD is the fourth-leading cause of disability in the U.S.

With more than $32 billion spent on COPD-related patient care in 2010, those costs are projected to increase to $49 billion by 2020, according to Medovex.